fluconazole has been researched along with flucytosine in 493 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (1.22) | 18.7374 |
| 1990's | 178 (36.11) | 18.2507 |
| 2000's | 147 (29.82) | 29.6817 |
| 2010's | 123 (24.95) | 24.3611 |
| 2020's | 39 (7.91) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Clark, AM; ElSohly, HN; Jacob, MR; Li, XC; Nagle, DG; Smillie, TJ; Walker, LA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chapeland-Leclerc, F; Chastin, C; Florent, M; Gibot-Leclerc, S; Jean, D; Noël, T; Papon, N; Villard, J | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Gesztelyi, R; Kardos, G; Kelentey, B; Majoros, L; Sóczó, G; Varga, I | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP | 1 |
| Jeong, SH; Lee, JY; Nho, JH; Ryu, CK | 1 |
| Hata, M; Kitamura, A; Nakajima, R; Someya, K; Takemura, M | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Chapeland-Leclerc, F; Chastin, C; Da Silva, B; Fitton-Ouhabi, V; Florent, M; Noël, T; Papon, N; Ruprich-Robert, G | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Hong, JA; Kim, A; Lee, JY; Ryu, CK; Song, AL; Yoon, JH | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Hong, JA; Kim, A; Kim, YH; Nho, JH; Ryu, CK; Yoon, JH | 1 |
| Im, HA; Kim, A; Kim, JY; Kim, YH; Ryu, CK; Yoon, JH | 1 |
| Im, HA; Kim, A; Kim, JY; Ryu, CK; Song, AL; Yoon, JH | 1 |
| Chovatia, PT; Parekh, HH; Pathak, RB | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Im, HA; Kim, A; Kim, JY; Ryu, CK | 1 |
| Kumar, S; Mishra, NN; Shukla, PK; Tandon, VK | 1 |
| Hong, JA; Ryu, CK; Song, AL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
| Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fang, XF; Gao, WW; Gopala, L; Li, D; Tangadanchu, VKR; Zhou, CH | 1 |
| Ji, C; Li, J; Li, W; Liu, N; Sheng, C; Tu, J; Yang, W; Yun, Z | 1 |
| Van Cutsem, J | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Bava, AJ; Negroni, R | 1 |
| Büchner, T; Roos, N | 1 |
| Lode, H; Schaberg, T | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Mocsny, N | 1 |
| Harms, K; Herting, E; Schiffmann, JH; Speer, CP | 1 |
| Hiraki, S; Kimura, I; Kodani, T; Maeda, T; Moritani, Y; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Uji, H | 1 |
| Kurita, N; Mikami, Y; Miyaji, M; Scalarone, GM; Uno, J; Yazawa, K | 1 |
| Cosnefroy, JY; Dujardin, P; Ferrari, E; Gari-Toussaint, M; Lefichoux, Y; Michiels, JF; Paquis, P; Taillan, B | 2 |
| Bernacer, B; Carrasco, R; Navarro, V; Nieto, A; Rodríguez, M; Roig, P; Salavert, M | 1 |
| Powderly, WG | 2 |
| Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J | 1 |
| Larsen, RA | 2 |
| Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB | 1 |
| Glück, T; Weber, P; Wiedmann, KH | 1 |
| Brockmeyer, NH; Goos, M; Hantschke, D; Hengge, UA; Olbricht, T | 1 |
| Bradley, SF; Kauffman, CA; Ross, SC; Weber, DR | 1 |
| Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR | 1 |
| Sugar, AM | 1 |
| Benson, JD; Padhye, AA; Sides, EH | 1 |
| Shindo, K | 1 |
| Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J | 1 |
| Dettori, G; Manzara, S; Morace, G | 1 |
| Chan, PC; Chau, SP; Cheng, IK; Lim, W | 1 |
| Aggarwal, R; Gibb, AP; Swainson, CP | 1 |
| Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG | 1 |
| Ikemoto, H | 1 |
| Ruf, B | 1 |
| Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ | 1 |
| Chan, LS; Larsen, RA; Leal, MA | 1 |
| Powell, G; Reents, SB | 1 |
| Watanabe, K | 2 |
| Fujita, S; Hisazumi, H; Nishikawa, T; Ohkawa, M; Takashima, M; Tokunaga, S; Wheat, RW | 1 |
| Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G | 1 |
| Dupont, B | 2 |
| Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
| Burns, RJ; Cochius, JI; Willoughby, JO | 1 |
| Polak, A | 1 |
| Walsh, TJ | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Barchiesi, F; McGough, DA; Nguyen, MH; Rinaldi, MG; Yu, VL | 1 |
| Barbarini, G; Barbaro, G; Di Lorenzo, G | 2 |
| Atkinson, BA; Bocanegra, R; Bouthet, C; Correa, A; Graybill, JR; Luther, MF | 1 |
| Conrad, PD; Kamitsuka, MD; Nugent, NA; Swanson, TN | 1 |
| Bale, M; Buschelman, B; Cooper, CR; Espinel-Ingroff, A; Lancaster, M; McGinnis, MR; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Hoeprich, PD | 1 |
| Berenguer, J; Bouza, E; Fernández-Baca, V; Sánchez, R | 1 |
| Hall, MA; Hitchcock, RJ; Malone, PS; Pallett, A | 1 |
| Barry, AL; Pfaller, MA | 2 |
| Denning, DW; Ganguli, LA; Keaney, MG; Law, D; Moore, CB; Wardle, HM | 1 |
| Kreis, H; Legendre, C; Page, B; Thervet, E | 1 |
| Baltch, AL; Franke, MA; Gordon, MA; Louie, A; Smith, RP | 1 |
| Hay, RJ | 1 |
| Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK | 1 |
| Baker, AS; D'Amico, DJ; Park, SS; Paton, B | 1 |
| Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
| Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
| Bauer, M; Bozzette, SA; Forthal, D; Haghighat, D; Jones, BE; Larsen, RA; Leal, MA; Leedom, JM; McCutchan, JA; Tilles, JG | 1 |
| Cunningham, C; Gross, S; Marr, B; Weiner, L | 1 |
| Ariyoshi, H; Hamajima, N; Hotta, T; Kodera, Y; Murate, T; Naito, K; Naoe, T; Ogura, M; Saito, H; Tanaka, M | 1 |
| Espinel-Ingroff, A | 2 |
| Joly, V | 1 |
| Solomkin, JS | 1 |
| Bale, M; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Bale, MJ; Buschelman, B; Espinel-Ingroff, A; Lancaster, M; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Amici, G; Bocci, C; Grandesso, S; Maresca, MC; Mottola, A; Teodori, T; Virga, G | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC; Paetznick, V; Rex, JH | 1 |
| Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
| Bickers, DR | 1 |
| al Khayat, R; Courdavault, L; Michel, C; Mignon, F; Roux, P; Viron, B | 1 |
| Bhakdi, S; Maier, F; Martin, E | 1 |
| Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S; Mitsutake, K; Miyazaki, H; Miyazaki, T; Tanaka, K; Tomono, K | 1 |
| Aznar, C; Boccon-Gibod, L; Landman, J; Lasfargues, G; Leverger, G; Tabone, MD | 1 |
| Uchida, K; Yamaguchi, H | 1 |
| Karp, JE; Merz, WG; Miller, CB; Rinaldi, MG; Saral, R; Wingard, JR | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 1 |
| Menon, T; Ponnuvel, KM; Rama, CP | 1 |
| Aoba, S; Hasegawa, O; Komiyama, A | 1 |
| Della-Latta, P; Oleinik, EM; Rinaldi, MG; Saiman, L | 1 |
| Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV | 1 |
| Kaku, M; Koga, H; Kohno, S; Maesaki, S; Yamada, H | 1 |
| Akiba, Y; Matsumoto, H; Nakano, H; Onodera, S; Osanai, S | 1 |
| Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM | 1 |
| Fothergill, AW; Rinaldi, MG; To, WK | 1 |
| Criddle, RS; Edwards, JE; Fu, Y; Ghannoum, MA; Ibrahim, AS; Mortara, LA; Shafiq, MC | 1 |
| Elliott, BR; Kartalija, M; Kaye, K; Liu, Q; Sande, MA; Täuber, MG; Tureen, JH | 1 |
| Okazawa, Y; Tosaka, M; Yamane, N | 1 |
| Martinez-Suarez, JV; Rodriguez-Tudela, JL | 1 |
| Kume, H; Murase, S | 1 |
| Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Berrouane, YF; Hollis, RJ; Pfaller, MA | 1 |
| Edwards, JE; Ghannoum, MA; Haubrich, RH; Larsen, RA; Leal, MA; Lewis, RJ; Milefchik, EN; Richie, JA; Witt, MD | 1 |
| Fujita, S | 1 |
| Bryant, KK; Lewis, JJ; Rabalais, GP; Samiec, TD | 1 |
| Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU | 1 |
| Berenguer, J; Martínez-Suárez, JV; Rodríguez-Tudela, JL; Sanchez, R | 1 |
| Bauer, M; Diamond, DM; Ding, JC; Graybill, JR; Larsen, RA; Leal, ME; Rinaldi, MG; Weiner, JM | 1 |
| Anaissie, EJ; Ensign, LG; Espinel-Ingroff, A; Galgiani, JN; Hitchcock, CA; LaRocco, M; Paetznick, VL; Patterson, T; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Love, DN; Malik, R; Medeiros, C; Wigney, DI | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Chabior, M; Czarniak, P; Irga, N; Kosiak, W; Ratajczak, B; Samet, A; Wierzba, J | 1 |
| Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Alonso, J; Iglesias, L; Rodriguez-Peralto, JL; Romero, G; Sanchez-Albisua, B; Vanaclocha, F | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 3 |
| Igari, J; Yamane, N | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Graybill, JR; Najvar, LK; Nguyen, MH; Yu, CY | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Digranes, A; Lassen, J; Nilsen, K; Sandven, P; Tjade, T | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| Cloud, GA; Dismukes, WE; Graybill, JR; Hamill, RJ; Johnson, PC; Kerkering, T; Moskovitz, BL; Powderly, WG; Saag, MS; Sobel, JD; Tuazon, CU; van der Horst, CM | 1 |
| Bauer, M; Diamond, DM; Ding, JC; Graybill, JR; Johnson, D; Larsen, RA; Leal, MA; Najvar, L; Thomas, AM; Williams, BK | 1 |
| Graybill, JR | 2 |
| Jaruratanasirikul, S | 1 |
| Casado, JL; Cobo, J; Corral, I; Moreno, A; Navas, E; Oliva, J; Pintado, V; Quereda, C | 1 |
| Lee, K; Scherer, WJ | 1 |
| Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
| Yamaguchi, H | 2 |
| Kauffman, CA; Spiegel, JE; Tiballi, RN; Zarins, LT | 1 |
| Berenguer Berenguer, J | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Barnes, RA; Flanagan, PG | 1 |
| Gayowski, T; Marino, IR; Singh, N | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
| Bauer, M; Daniel, BE; Diamond, DM; Ding, JC; Graybill, JR; Johnson, D; Larsen, RA; Leal, MA; Najvar, L; Thomas, AM; Williams, BK | 1 |
| Seaton, RA | 1 |
| Gould, IM; Kunova, A; Milne, K; Wood, W | 1 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Blaschke-Hellmessen, R; Schwarze, R; Seebacher, C | 1 |
| Augustine, K; Izumi, T; Matsumoto, K; Mayanja-Kizza, H; Mitarai, S; Mugerwa, R; Nagatake, T; Nalongo, K; Oishi, K; Watanabe, K; Yamashita, H | 1 |
| Ellepola, AN; Samaranayake, LP | 5 |
| Aiyar, S; Haq, JA; Menon, BS; Noh, LM; Shuaib, IL; Zamari, M | 1 |
| Arikan, S; Chen, Y; Coffman, S; Heffner, T; Lozano-Chiu, M; Messer, SA; Pfaller, MA; Rennie, R; Rex, JH; Sand, C; Wang, J; Yamane, N | 1 |
| Johnson, EM; Rogers, TR; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Ghannoum, M; Jessup, C; Mbidde, E; Messer, S; Pfaller, M; Tumberland, M; Zhang, J | 1 |
| Clemons, KV; McCullough, MJ; Stevens, DA | 1 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Alonso, M; García, F; Gatell, JM; Mallolas, J; Miró, JM; Ortega, M; Soriano, A; Soriano, E | 1 |
| de Pauw, BE; Meunier, F | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Chang, HW; Chang, WN; Chuang, YC; Lu, CH | 1 |
| Martín Dávila, P; Muñoz Labián, V; Pintado García, V; Quereda Rodríguez-Navarro, C | 1 |
| de Vries, HG; Eikelboom, MC; Kuipers, ME; Meijer, DK; Swart, PJ | 1 |
| Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Bash, E; Giladi, M; Izkhakov, E; Orni-Wasserlauf, R; Polacheck, I; Siegman-Igra, Y | 1 |
| Azevedo, V; Caligiorne, RB; Carmo, FH; Melillo, PH; Peluso, CP; Resende, MA | 1 |
| Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L | 1 |
| Chang, HC; Chang, JJ; Chang, TC; Huang, AH | 1 |
| Chang, SC; Chen, YC; Hsieh, WC; Hung, CC; Luhbd, KT; Pan, YS; Shih, CC | 1 |
| Braxton, GR; Cawley, MJ; Guilday, RE; Haith, LR; Patton, ML; Reilly, KJ | 1 |
| Ciblak, MA; Clayton, GE; Elie, CM; Li, RK | 1 |
| Hartmann, M; Kappe, R; Prariyachatigul, C; Rimek, D; Zimmermann, T | 1 |
| Büchner, T; Essink, M; Fegeler, W; Roos, N; Silling, G | 1 |
| Anndo, T | 1 |
| Akgün, Y; Anğ, O; Erturan, Z; Kiraz, N | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín-Mazuelos, E; Recio, FJ | 1 |
| Haapasalo, MP; Meurman, JH; Samaranayake, LP; Waltimo, TM; Ørstavik, D | 1 |
| García, MT; Llorente, MT; Mínguez, F; Prieto, J | 1 |
| Amerongen, AV; Helmerhorst, EJ; Reijnders, IM; Simoons-Smit, IM; van't Hof, W; Veerman, EC; Walgreen-Weterings, E | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Kox, WJ; Tietz, HJ; Wauer, HJ; West, C | 1 |
| Jurga, L; Krcmery, V; Mateicka, F; Sulcová, M | 1 |
| André, MH; Lortholary, O | 1 |
| Dupont, H | 1 |
| Huang, YC; Kao, HT; Kuo, AJ; Lin, TY | 1 |
| Bossi, P; Bricaire, F; Caumes, E; Katlama, C; Rollot, F; Tubiana, R; Zeller, V | 1 |
| Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
| Cook, PP | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Liao, W; Wen, H; Yao, Z | 1 |
| Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín Mazuelos, E; Quindós, G; Serrano, C; Valverde, A | 1 |
| Nakanishi, T; Sekimizu, K | 1 |
| Batisse, D; Karmochkine, M; Kazatchkine, MD; Mikol, J; Mrejen, S; Piketty, C; Rambeloarisoa, J; Thiebaut, JB; Weiss, L | 1 |
| Clarke, MA; Hedderwick, SA; Jones, JM; Sarsam, MA | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Bergervoet, M; Meis, JF; Meletiadis, J; Mouton, JW; Punt, NC; Te Dorsthorst, DT; Verweij, PE | 1 |
| Maliner, LI | 1 |
| Paterson, DL; Singh, N | 1 |
| Acus, R; Askew, M; Dipersio, J; Kodali, P; Silverberg, D | 1 |
| Berrouschot, J; Günther, P; Hermann, W; Kühn, HJ; Wagner, A | 1 |
| Ghannoum, MA; Hossain, MA; Long, L; Mukherjee, PK; Reyes, G | 1 |
| Li, T; Liu, Z; Qin, S; Sheng, R; Wang, A | 1 |
| Balci, I; Meriç, G; Zer, Y | 1 |
| Cartelle, M; Cuenca-Estrella, M; Durán, MT; Gil, E; Guerrero, A; Molina, F; Rodríguez-Tudela, JL | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Brèthes, D; Chastin, C; François, F; Noël, T; Paumard, P; Villard, J | 1 |
| Hamdan, JS; Moraes, EM; Prímola, NS | 1 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Kretzer, V; Lawrenz, K; Pollak, A; Pumberger, W; Wald, M; Weninger, M; Zaknun, D | 1 |
| Barchiesi, F; Bille, J; Chryssanthou, E; Cuenca-Estrella, M; Denning, DW; Donnelly, JP; Dromer, F; Dupont, B; Moore, CB; Rex, JH; Richardson, MD; Rodríguez-Tudela, JL; Sancak, B; Verweij, PE | 1 |
| Girmenia, C; Martino, P; Venditti, M | 1 |
| Fehér, J; Lengyel, G | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Bauer, M; Graybill, JR; Larsen, RA; Thomas, AM | 1 |
| Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Aranda, JV; Frattarelli, DA; Giacoia, GP; Reed, MD | 1 |
| Brouwer, AE; Chierakul, W; Griffin, GE; Harrison, TS; Larsen, RA; Rajanuwong, A; White, NJ | 1 |
| Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B | 1 |
| Archer, J; Lane, M; McBride, J | 1 |
| Al-Fattani, MA; Douglas, LJ | 1 |
| Booton, GC; Dunnebacke, TH; Schuster, FL; Yagi, S | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Ye, J | 1 |
| Alfaro, B; Avila-Aguero, ML; Canas-Coto, A; Caro, MA; Paris, MM; Ulloa-Gutierrez, R | 1 |
| Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
| Bicanic, T; Harrison, TS | 1 |
| Feiszt, P; Kardos, G; Majoros, L; Szabó, B | 1 |
| Steinbach, WJ | 1 |
| McGirt, MJ; Rigamonti, D; Williams, MA; Woodworth, GF | 1 |
| Kappe, R; Rimek, D; Singh, J | 1 |
| Bouchoux, J; Chapeland-Leclerc, F; Chastin, C; Goumar, A; Noël, T; Villard, J | 1 |
| Bedard, M; Lulic-Botica, M; Natarajan, G; Pappas, A; Rongkavilit, C | 1 |
| Aparicio, M; García Ramón, R; Miguel, A; Molina, P; Puchades, MJ | 1 |
| Fernández-Torres, B; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Andre, JM; Freydiere, AM; Picot, S; Piens, MA; Putet, G | 1 |
| Bicanic, T; Brouwer, AE; Harrison, TS; Macallan, DC; Macsween, KF; Marsh, H | 1 |
| Brouwer, N; Jamie, J; Kohen, J; Vemulpad, S | 1 |
| Beytout, J; Corbain, V; Ferrier, A; Gibold, X; Gourdon, F; Husson, A; Irthum, P; Laurichesse, H; Lesens, O; Vidal, M | 1 |
| Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Kvinesdal, B; Rosendahl, M | 1 |
| Abdul, M; Arpin, M; Dannaoui, E; Dromer, F; Favel, A; Lortholary, O; Michel-Nguyen, A; Piens, MA | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Candido, RC; Ferreira, JC; Pedroso, RS | 1 |
| Borowska-Rybus, B; Grzegorczyk, W; Kupś, J; Woźniakowska-Gesicka, T | 1 |
| Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| de Souza, JA | 1 |
| Decembrino, L; Stronati, M | 1 |
| Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Chaturvedi, AK; Duggineni, S; Kumar, M; Kundu, B; Shukla, PK; Srivastava, G | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Hirata, Y; Kobayashi, K; Miyoshi, T; Oka, S; Tsuji, M; Yokote, T | 1 |
| Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Khakoo, RA; Khan, FA; Slain, D | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Espinel-Ingroff, A; Quindós, G; Ruesga, M; Villar-Vidal, M | 1 |
| Andes, D; Smith, J | 1 |
| Choi, JD; Friedman, AH; Powers, CJ; Sampson, JH; Vredenburgh, JJ | 1 |
| Bozzette, SA; Haubrich, R; Larsen, RA; Leal, MA; Leedom, JM; McCutchan, JA; Milefchik, E; Tilles, JG | 1 |
| Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Pasqualotto, AC | 1 |
| Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH | 1 |
| Klassen, R; Meinhardt, F; Paluszynski, JP | 1 |
| Dedicoat, M; Dlamini, S; Paul, N; Sloan, D | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Cisalpino, PS; da Costa César, G; de Carvalho, IR; dos Anjos Martins, M; Kohler, LM; Santos, DA; Soares, BM | 1 |
| Huang, J; Liu, H; Wu, B; Zhang, T; Zhang, W | 1 |
| Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Bosshard, PP; Calligaris-Maibach, RC; Georgi, A; Meyer, S; Schneemann, M; Tintelnot, K; Weber, R | 1 |
| Borrajo Prol, M; Conde Rivera, O; Novoa Fernández, E; Pérez Melón, C | 1 |
| Albini, TA; Couvillion, SS; Davis, JL; Dubovy, SR; Wykoff, CC | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Hazen, KC; Pettit, RK; Repp, KK | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Bobadilla-Del Valle, M; Castaño, I; De Las Peñas, A; Lavaniegos-Sobrino, MT; Ponce de León, A; Ramírez-Zavaleta, CY; Rangel-Cordero, A; Sifuentes-Osornio, J | 1 |
| Hughes, RA; Malaiya, R; Mohd, TA; Rachapalli, SM | 1 |
| Gao, F; Jiang, PF; Shen, SX; Shui, QX; Xia, ZZ; Yu, HM; Zhou, BL | 1 |
| Bagheri, F; Cervellione, KL; Marino, W; Maruf, M; Santucci, T | 1 |
| Harrison, TS; Hosseinipour, MC; Jackson, A; Jaffar, S; Jarvis, JN; Kamwendo, D; Kanyemba, C; Kenala, J; Namarika, D; Nussbaum, JC; Phulusa, J; van der Horst, CM | 1 |
| Krzyściak, P; Macura, AB | 1 |
| Eisen, DB; Fung, MA; Sharon, V | 1 |
| Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
| Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K | 1 |
| Fisher, JF; Kauffman, CA; Newman, CA; Sobel, JD | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Abele-Horn, M; Beer, M; Hebestreit, H; Kunzmann, S; Radike, K | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Hai, W; Jianghan, C; Julin, G; Nan, X; Wanqing, L; Xiaojun, W; Yuanjie, Z | 1 |
| Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
| Celebi, S; Hacimustafaoglu, M | 1 |
| Hamoud, S; Hayek, T; Keidar, Z | 1 |
| Bauer, M; Larsen, RA; Thomas, AM | 1 |
| Ahmad, S; Chandy, R; Joseph, L; Khan, Z | 1 |
| Boekhout, T; Chaicumpar, K; Chakrabarti, A; Chowdhary, A; Curfs-Breuker, I; Hagen, F; Ikeda, R; Imran, D; Ingviya, N; Khan, Z; Khayhan, K; Klaassen, CH; Liao, W; Meis, JF; Mouton, JW; Pan, W; Sjam, R; Sriburee, P; Taj-Aldeen, SJ; Wahyuningsih, R | 1 |
| Espinosa-Heidmann, D; Harper, T; Jamie Miller, G; Kresch, ZA | 1 |
| Ford, N; Milani, B | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Chikasema, M; Harrison, TS; Hosseinipour, MC; Jackson, AT; Jaffar, S; Jarvis, JN; Kanyemba, C; Namarika, D; Nussbaum, JC; Phulusa, J; van der Horst, C | 1 |
| Caggiano, G; Carone, A; Corbo, F; Franchini, C; Montagna, MT; Muraglia, M; Piarulli, M; Rosato, A; Schiavone, BI | 1 |
| Kim, HR; Lee, MK; Yu, N | 1 |
| Clerihew, L; McGuire, W | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Birkenkamp, KE; Boulware, DR; Meya, DB; Rajasingham, R; Rolfes, MA | 1 |
| Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S | 1 |
| Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
| Buzina, W | 1 |
| Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Bratton, EW; Chastain, CA; El Husseini, N; Juliano, JJ; Lee, MS; Perfect, JR; Poole, C; Stürmer, T; Weber, DJ | 1 |
| Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
| Fothergill, AW; Sanders, C; Wiederhold, NP | 1 |
| DeSimone, JA; Fennelly, AM; Moussouttas, M; Murphy, LC; Slenker, AK | 1 |
| Bak, N; Byth, K; Chen, SC; Currie, BJ; Hajkowicz, K; Heath, CH; Kidd, S; Korman, TM; Marriott, D; McBride, WJ; Meyer, W; Murray, R; Playford, EG; Slavin, MA; Sorrell, TC | 1 |
| Day, J; Dromer, F; Harrison, TS; Lortholary, O; Loyse, A | 1 |
| Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H | 1 |
| Bachmann, A; Bonkat, G; Braissant, O; Gasser, TC; Wernli, L | 1 |
| Bethlendy, G; Kravets, A; Rustchenko, E; Welle, S; Yang, F | 1 |
| Edlind, T; Gygax, SE; Katiyar, S; Steier, Z; Toner, G; Vermitsky, JP | 1 |
| Deng, L; Hu, DD; Hu, GH; Jiang, YY; Li, DD; Wang, Y; Zhao, LX | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Li, M; Liu, J; Peng, FH; Tan, F; Wang, X; Yuan, Y; Zhong, XF; Zhong, YH | 1 |
| Lin, DF; Lu, X; Shen, C; Yao, ZW | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Molter, CM; Papendick, R; Zuba, JR | 1 |
| Assi, M; Chaaban, S; Wheat, LJ | 1 |
| Brillowska-Dabrowska, A; Dzierzanowska-Fangrat, K; Gucwa, K; Milewski, S; Naumiuk, L; Romanowska, E; Szweda, P; Wojciechowska-Koszko, I | 1 |
| Newsome, J; Nguyen, D | 1 |
| Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T | 1 |
| Ishiguro, T; Odashima, K; Shimizu, Y; Sugita, Y; Takayanagi, N | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Rughwani, N; Sangarlangkarn, A | 1 |
| Benbouzid, S; Elhaj, SA; Garcia, H; Guitard, J; Hennequin, C; Peltier, J; Rondeau, E; Tligui, M | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Aliredjo, RP; de Jong, PY; de Sévaux, RG; Nooijen, S; van Spil, WE; Verhave, JC | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Adeyemi, BO; Ross, A | 1 |
| Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X | 1 |
| Bouchrik, M; Boumhil, L; Iken, M; Lemkhente, Z; Lmimouni, B; Naoui, H; Uwingabiye, J; Zohoun, AG | 1 |
| Al-Hayek, S; Aliyu, SH; Dev, H; Lawrentschuk, N; Papa, N; Toner, L | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Boulware, DR; Merry, M | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Behan, JW; Declerck, B; Kim, GH; Rodriguez, PG; Zhu, TH | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J | 1 |
| Ma, P; Qian, J; Qu, L; Yin, Z | 1 |
| Hatlen, TJ; Murphy, RA; Persichino, JG | 1 |
| Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F | 1 |
| Aboubakar, T; Bellet, V; Bertout, S; Delaporte, E; Doumbia, A; Drakulovski, P; Kassi, FK; Kouakou, GA; Krasteva, D; Menan, HIE; Reynes, J; Roger, F; Valérie, BA; Yavo, W | 1 |
| Abbas, H; Abbas, N; CiFuentes Kottkamp, A; Cindrich, R; Singh, M | 1 |
| Adams, J; Bicanic, T; Bradley, J; Bright, P; Chan, AK; Chanda, D; Chawinga, C; Chen, T; Ellis, J; Gaskell, K; Harrison, TS; Heyderman, RS; Hosseinipour, MC; Jaffar, S; Kalata, N; Kanyama, C; Karunaharan, N; Kouanfack, C; Lakhi, S; Lalloo, DG; Lesikari, S; Lontsi, S; Lortholary, O; Loyse, A; Lupiya, D; Mapoure, YN; Mfinanga, S; Molloy, SF; Mwaba, P; Ndong, JG; Peirse, M; Sini, V; Stone, N; Temfack, E; van der Horst, C; van Oosterhout, JJ; Wang, D | 1 |
| Kuang, W; Li, M; Liao, J; Liu, J; Peng, F; Xu, L; Yi, H; Zhang, Q; Zhu, C | 1 |
| Blice, JP; Johnson, WJ; Lee, KK | 1 |
| Abebaw, Y; Bitew, A | 1 |
| Eshun-Wilson, I; Ford, N; Jarvis, JN; Li, T; Rouse, B; Shapiro, AE; Tenforde, MW | 1 |
| Benjamin, LA; Ellis, JP; Harrison, TS; Heyderman, RS; Joekes, EC; Kalata, N; Kampondeni, S; Lalloo, DG | 1 |
| Aliyu, SH; Andrieux-Meyer, I; Bicanic, T; Boulware, DR; Burry, J; Chan, A; Chanda, D; Chiller, T; Cohn, J; Day, J; Denning, D; Doherty, M; Dromer, F; Ford, N; Gondwe-Chunda, L; Govender, N; Harrison, TS; Heyderman, R; Hosseinipour, M; Jaffar, S; Jarvis, JN; Kalata, N; Kanyama, C; Klausner, JD; Kouanfack, C; Koulla-Shiro, S; Lakhi, S; Lalloo, D; Le, T; Lesikari, S; Lortholary, O; Loyse, A; Mapoure, Y; Mfinanga, S; Mghamba, J; Migone, C; Molloy, SF; Muzoora, C; Mwaba, P; Ngoma, J; Nyirenda, R; Oladele, R; Perfect, C; Ramadhani, A; Ribeiro, I; Rodrigues, M; Schutz, C; Shimwela, M; Shroufi, A; Sini, V; Stack, M; Temfack, E; Van der Horst, C; van Oosterhout, J; Wilson, D | 1 |
| Alanio, A; Alufandika, M; Boulware, DR; Boyer-Chammard, T; Chen, T; Dromer, F; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Kanyama, C; Lalloo, DG; Lawrence, DS; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Muzoora, C; Mwandumba, HC; Ndhlovu, CE; Niessen, L; Schutz, C; Stott, KE; Wang, D; Youssouf, N | 1 |
| Kim, S; Lee, DG; Woo, ER | 1 |
| Eshun-Wilson, I; Ford, N; Garner, P; Migone, C | 1 |
| Cheng, JH; Harrison, TS; Huang, LP; Jiang, YK; Wang, RY; Wang, X; Zhao, HZ; Zhou, LH; Zhu, LP | 1 |
| Al-Hatmi, AMS; Alves, SH; de Azevedo, MI; Loreto, ES; Rossato, L; Santurio, JM; Venturini, TP | 1 |
| Chan, AK; Chanda, D; Chen, T; Harrison, TS; Heyderman, RS; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Kanyama, C; Kivuyo, S; Kouanfack, C; Lakhi, S; Lortholary, O; Loyse, A; Mfinanga, S; Molloy, SF; Mwaba, P; Mwenge, L; Niessen, LW; Shiri, T; Temfack, E | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Jandhyala, D; Sohail, MR; Stahr, DC; Tan, EM | 1 |
| Chong, Y; Jie, Y; Li, X; Li, Z; Liu, Y; Yan, Y; Zheng, X | 1 |
| Adams, J; Bright, P; Chan, AK; Chawinga, C; Harrison, TS; Heyderman, RS; Hosseinipour, MC; Jaffar, S; Kanyama, C; Lalloo, DG; Lortholary, O; Loyse, A; Lupiya, D; Molloy, SF; van Oosterhout, JJ | 1 |
| Alanio, A; Boyer-Chammard, T; Harrison, TS; Jarvis, JN; Lortholary, O; Temfack, E | 1 |
| Becker, SL; Fuchs, V; Gerkrath, J; Graf, B; Hamprecht, A; Han, CO; Heckmann, D; Held, J; Hogardt, M; Idelevich, EA; Küpper-Tetzel, CP; McCormick-Smith, I; Rickerts, V; Schwarz, R; Sedlacek, L; Selb, R; Wilmes, D | 1 |
| Alanio, A; Boyer-Chammard, T; Delliere, S; Lanternier, F; Lawrence, D; Lortholary, O; Loyse, A; Temfack, E | 1 |
| Bellet, V; Bertout, S; Chabrol, A; Delaporte, E; Doumbia, A; Drakulovski, P; Kakou, A; Kassi, FK; Krasteva, D; Landman, R; Menan, HEI; Reynes, J; Roger, F | 1 |
| Cheng, J; Tao, R; Xu, L; Zhao, Q; Zhu, B | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Abe, M; Anzawa, K; Futatsuya, T; Hoshino, Y; Mochizuki, T; Shoji, A | 1 |
| Jeng, A; Kalinoski, T; Malenfant, J; Yim, C | 1 |
| Pea, F | 1 |
| Lacy, AJ; Murphy, LS; Shah, KS; Smith, AT | 1 |
| Chau, NVV; Chau, TTH; Day, JN; Huong, LNP; O'Connor, L; Van Anh, D; Wolbers, M | 1 |
| Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A | 1 |
| Deng, X; Gan, Q; Jiang, Y; Li, M; Liu, J; Peng, F; Wang, Y; Xu, X | 1 |
| Boulware, DR; de Albuquerque Moraes, C; de Oliveira, ACP; de Siqueira, REB; Marcusso, R; Miranda, NFB; Vidal, JE | 1 |
| Alufandika, M; Bicanic, T; Day, JN; Harrison, TS; Hope, W; Jarvis, JN; Lalloo, DG; Loyse, A; Mwandumba, HC; Perfect, JR; Stott, KE | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Cho, YJ; Han, SI; Lim, SC | 1 |
| Berman, J; Gao, L; Gritsenko, V; Jiang, YY; Lu, H; Yang, F; Zhen, C | 1 |
| Chen, W; Dai, H; Hu, X; Li, H; Liu, H; Qiao, S; Sun, L; Sun, S; Wang, K; Zhang, S; Zhao, X | 1 |
| Bellet, V; Bertout, S; Drakulovski, P; Gouveia, T; Krasteva, D; Pottier, C; Roger, F | 1 |
| Boulware, DR; Boyer-Chammard, T; Chawinga, C; Chen, T; Comins, K; Harrison, TS; Hlupeni, A; Hope, W; Hosseinipour, MC; Jaffar, S; Jarvis, JN; Jjunju, S; Kagimu, E; Kanyama, C; Kasibante, J; Lalloo, DG; Lawrence, DS; Leeme, T; Lortholary, O; Loyse, A; Meintjes, G; Meya, DB; Molloy, SF; Mosepele, M; Moyo, M; Mpoza, E; Mutata, C; Muzoora, C; Mwandumba, HC; Mzinganjira, H; Ndhlovu, CE; Nuwagira, E; Rhein, J; Rutakingirwa, MK; Schutz, C; Siamisang, K; Singh, A; Ssebambulidde, K; Tugume, L; van Widenfelt, E; Wang, D; Youssouf, N | 1 |
| Sheikh, AM; Tucker, M; Villanueva, MS | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Black, J; Boretti, L; Garcia, A; Govender, NP; Greene, GS; Harrison, TS; Madua, M; Mashau, RC; Meintjes, G; Meiring, ST; Menezes, C; Nel, J; Quan, VC; Reddy, DL; Shroufi, A; Stacey, S; Trivino-Duran, L; Venter, M | 1 |
| Lortholary, O; Temfack, E | 1 |
| Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L | 1 |
| Falci, DR; Pasqualotto, AC | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
| Chen, YC; Chung, WH; Ho, MW; Lai, YC; Lin, KH; Lin, YP | 1 |
| Cheng, JH; Jiang, YK; Luo, Y; Wang, X; Zhao, HZ; Zhou, LH; Zhu, LP; Zhu, RS | 1 |
| Day, JN; Flower, B; Ngan, NTT | 1 |
| Chiller, TM; Ford, N; Rajasingham, R; Shapiro, AE; Tenforde, MW | 1 |
| Boulware, DR; Harrison, TS; Hosseinipour, MC; Jarvis, JN; Lawrence, DS; Lortholary, O; Meintjes, G; Mosepele, M; Mwandumba, HC | 1 |
| Golubykh, K; Holleran, L; Kovalenko, I; Qurashi, S; Saleem, T | 1 |
| Harrison, TS; Jarvis, JN; Lawrence, DS; Maphane, L; Meya, DB; Moshashane, N; Nabaggala, G; Seeley, J; Ssali, A | 1 |
| Alanio, A; Bailly, E; Bellanger, AP; Bonhomme, J; Botterel, F; Bouchara, JP; Bougnoux, ME; Bourgeois, N; Brun, S; Cassagne, C; Cassaing, S; Chouaki, T; Costa, D; Dalle, F; Dannaoui, E; Debourgogne, A; Delhaes, L; Desbois-Nogard, N; Dupont, D; Durieux, MF; Fekkar, A; Gangneux, JP; Hasseine, L; Houzé, S; Huguenin, A; Lachaud, L; Le Gal, S; Letscher-Bru, V; Mahinc, C; Maubon, D; Mercier, V; Morio, F; Nourrisson, C; Perraud-Cateau, E; Sasso, M; Sendid, B; Yéra, H | 1 |
| Aberg, JA; Badal-Faesen, S; Bukuru, A; Clifford, DB; Hogg, E; Komarow, L; Lagat, D; Lalloo, UG; Langat, D; Larsen, RA; Mave, V; McKhann, A; Pillay, S; Samaneka, W; Supparatpinyo, K; Ticona, E | 1 |
| Almeida, JDR; Frickmann, H; Lacerda, MVG; Sousa, NSO; Souza, JVB | 1 |
| Bive, BZ; Bontems, S; Hayette, MP; Lelo, GM; Mudogo, CN; Sacheli, R; Zakayi, PK | 1 |
| Dubé, AK; Durand, R; Fijarczyk, A; Jalbert-Ross, J; Landry, CR | 1 |
69 review(s) available for fluconazole and flucytosine
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
Cryptococcal meningitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Neurologic Examination; Nursing Assessment; Patient Education as Topic | 1992 |
Therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans | 1990 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1994 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Humans; Intensive Care Units; Risk Factors | 1993 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administration Routes; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Risk Factors; Treatment Outcome | 1994 |
Candida lusitaniae osteomyelitis in a premature infant.
Topics: Candidiasis; Diseases in Twins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Osteomyelitis | 1993 |
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Japan; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Methotrexate; Middle Aged; Opportunistic Infections | 1993 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
Candidal meningitis in HIV-infected patients: analysis of 14 cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Fungal; Middle Aged; Risk Factors | 1997 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Flucytosine; Humans; Immunotherapy; Itraconazole; Meningitis, Cryptococcal; Mice; Multicenter Studies as Topic; Vaccination | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
The management of cryptococcal meningitis in Papua New Guinea.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Cause of Death; Drug Combinations; Drug Monitoring; Fluconazole; Flucytosine; Humans; Hydrocortisone; Immunocompetence; Intracranial Hypertension; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal; Multicenter Studies as Topic; Papua New Guinea | 1996 |
[Candida infections in infancy and early childhood].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Risk Factors | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Fungemia; Histoplasmosis; Humans; Immunocompromised Host; Mycoses; Zygomycosis | 1999 |
[The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
Topics: Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1999 |
Molecular and biochemical mechanisms of drug resistance in fungi.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Flucytosine; Fungi | 1999 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; Fatal Outcome; Female; Fluconazole; Flucytosine; Fungemia; Humans; Immunocompromised Host; Male; Mycoses; Opportunistic Infections; Sputum; Trichosporon; Wound Infection | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Itraconazole; Lung Diseases, Fungal; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2000 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Time Factors | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Antifungals in systemic neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Humans; Infant, Newborn; Peptides; Peptides, Cyclic | 2004 |
Cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunotherapy; Intracranial Pressure; Meningitis, Cryptococcal; Prognosis; Treatment Outcome | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Cryptococcus neoformans; Deoxycholic Acid; Drainage; Drug Combinations; Female; Fluconazole; Flucytosine; HIV-1; Humans; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2005 |
Neonatal invasive candidiasis.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Incidence; Infant, Newborn; Infant, Very Low Birth Weight; Prognosis; Risk Factors; Sensitivity and Specificity | 2006 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antihypertensive Agents; Developing Countries; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Intracranial Hypertension; Meningitis, Cryptococcal | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross Infection; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units; Leukocyte Count; Mycological Typing Techniques; Neutrophils; Survival Rate; United States | 2011 |
Antifungal therapy for newborn infants with invasive fungal infection.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Mycoses; Randomized Controlled Trials as Topic | 2012 |
Aspergillus--classification and antifungal susceptibilities.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans | 2013 |
Candida cerebral abscesses: a case report and review of the literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Brain Abscess; Candida; Candidiasis; Child, Preschool; Diabetes Complications; Female; Fluconazole; Flucytosine; Humans; Infant; Male; Middle Aged; Substance Abuse, Intravenous; Young Adult | 2013 |
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Coinfection; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Treatment Outcome | 2014 |
[Cryptococcal meningitis].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2015 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole | 2015 |
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.
Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin | 2017 |
Treatment for HIV-associated cryptococcal meningitis.
Topics: Acetazolamide; Acute Disease; Adult; Amphotericin B; Antifungal Agents; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Health Resources; HIV Infections; Humans; Induction Chemotherapy; Intracranial Hypertension; Meningitis, Cryptococcal; Network Meta-Analysis | 2018 |
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Topics: Africa; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcus neoformans; Developing Countries; Disease Management; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Guidelines as Topic; HIV Infections; Humans; Income; Meningitis, Cryptococcal; Survival Analysis | 2019 |
Recent advances in managing HIV-associated cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2019 |
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Deficiency Syndromes; Intracranial Hypertension; Meningitis, Cryptococcal; Risk Factors | 2019 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningoencephalitis | 2021 |
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Glucocorticoids; HIV Infections; Humans; Meningitis, Cryptococcal; Sertraline; Tamoxifen | 2022 |
An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2023 |
Searching for new antifungals for the treatment of cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans | 2023 |
24 trial(s) available for fluconazole and flucytosine
| Article | Year |
|---|---|
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluation; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Meningitis; Middle Aged; Recurrence | 1991 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Opportunistic Infections; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Esophagitis; Esophagoscopy; Female; Fluconazole; Flucytosine; Humans; Male | 1995 |
Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Pilot Projects; Prospective Studies; Survival Analysis | 1994 |
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method].
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Glucans; Humans; Japan; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Sugar Alcohols | 1994 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Drug Therapy, Combination; Esophagitis; Esophagoscopy; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Treatment Outcome | 1996 |
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Survival Analysis | 1997 |
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Uganda | 1998 |
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Neutropenia | 1999 |
Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male | 2001 |
Antifungal therapy for treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2000 |
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Colony Count, Microbial; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 2004 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Itraconazole; Leukemia, Myelomonocytic, Acute; Male; Retrospective Studies | 2007 |
Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Nausea; Prospective Studies; Treatment Outcome; Vomiting | 2008 |
Amphotericin B: the higher the dose, the higher the toxicity.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2008 |
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Topics: Administration, Oral; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Cerebrospinal Fluid; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Malawi; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome; Young Adult | 2010 |
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Malawi; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Topics: Administration, Oral; Adult; Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Male; Meningitis, Cryptococcal; Proportional Hazards Models | 2018 |
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Topics: Africa South of the Sahara; Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Cryptococcus neoformans; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Equivalence Trials as Topic; Fluconazole; Flucytosine; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Multicenter Studies as Topic; Time Factors; Treatment Outcome | 2018 |
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi.
Topics: Antifungal Agents; Fluconazole; Flucytosine; Humans; Malawi; Meningitis, Cryptococcal | 2020 |
Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2021 |
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Topics: Administration, Oral; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Meningitis, Cryptococcal | 2022 |
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
Topics: Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Meningitis, Cryptococcal | 2023 |
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Treatment Outcome | 2023 |
400 other study(ies) available for fluconazole and flucytosine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fatty Acids, Monounsaturated; Fluconazole; Gas Chromatography-Mass Spectrometry; Methylation; Microbial Sensitivity Tests; Molecular Structure; Peru; Plant Roots; Sphingolipids | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
Topics: Alleles; Antifungal Agents; Candida; Cloning, Molecular; Cytosine Deaminase; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Genetic Complementation Test; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pentosyltransferases; Plasmids; Sequence Analysis, DNA | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
Topics: Antifungal Agents; Candida tropicalis; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Time Factors | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole | 2009 |
Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles.
Topics: Animals; Antifungal Agents; Fungi; Indoles; Quinolines; Structure-Activity Relationship | 2009 |
Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis.
Topics: Acetic Acid; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzimidazoles; beta-Glucans; Blotting, Western; Cell Wall; Drug Resistance, Fungal; Fungi; Glucose; Leucine; Microbial Sensitivity Tests; Pyridines; Saccharomyces cerevisiae; Uridine | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.
Topics: Antifungal Agents; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Codon, Nonsense; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and antifungal activity of benzofuran-5-ols.
Topics: Antifungal Agents; Aspergillus; Benzofurans; Candida; Cryptococcus neoformans; Microbial Sensitivity Tests | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
Synthesis and antifungal activity of furo[2,3-f]quinolin-5-ols.
Topics: Antifungal Agents; Aspergillus; Candida; Hydroxyquinolines; Microbial Sensitivity Tests; Structure-Activity Relationship | 2011 |
Synthesis and antifungal activity of 6,7-bis(arylthio)-quinazoline-5,8-diones and furo[2,3-f]quinazolin-5-ols.
Topics: Antifungal Agents; Aspergillus; Candida; Chemistry, Pharmaceutical; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Microbial Sensitivity Tests; Models, Chemical; Quinazolines; Structure-Activity Relationship; Sulfhydryl Compounds | 2012 |
Synthesis and antifungal evaluation of pyrido[1,2-a]indole-1,4-diones and benzo[f]pyrido[1,2-a]indole-6,11-diones.
Topics: Antifungal Agents; Aspergillus flavus; Aspergillus niger; Candida albicans; Carbolines; Chemistry, Pharmaceutical; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Models, Chemical; Saccharomyces cerevisiae; Time Factors | 2012 |
Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship | 2012 |
Synthesis and antifungal activity of 1-thia-4b-aza-cyclopenta[b]fluorene-4,10-diones.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Fluorenes; Fungi; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2012 |
Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Benzoquinones; Catalysis; Cell Line; Dose-Response Relationship, Drug; Escherichia coli; Klebsiella pneumoniae; Mice; Micelles; Microbial Sensitivity Tests; Molecular Structure; Sporothrix; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Trichophyton; Water | 2012 |
Synthesis and antifungal evaluation of 7-arylamino-5,8-dioxo-5,8-dihydroisoquinoline-4-carboxylates.
Topics: Antifungal Agents; Aspergillus; Candida; Carboxylic Acids; Cryptococcus neoformans; Dose-Response Relationship, Drug; Isoquinolines; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
Novel potentially antifungal hybrids of 5-flucytosine and fluconazole: Design, synthesis and bioactive evaluation.
Topics: Antifungal Agents; Binding Sites; Candida albicans; Catalytic Domain; Drug Design; Fluconazole; Flucytosine; Fungi; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Docking Simulation; Quantum Theory; Sterol 14-Demethylase; Structure-Activity Relationship | 2017 |
Discovery of Novel Sertraline Derivatives as Potent Anti-
Topics: Antidepressive Agents; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Sertraline | 2022 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Fluconazole; Flucytosine; Fungemia; Germany; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Lung Diseases, Fungal; Risk Factors | 1992 |
[Six cases of primary pulmonary cryptococcosis].
Topics: Adult; Aged; Biopsy; Bronchoscopy; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Radiography, Thoracic | 1992 |
Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans.
Topics: Candida albicans; Drug Synergism; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1992 |
[Blastomycosis localized in the brain stem].
Topics: Adult; Blastomyces; Blastomycosis; Brain Abscess; Brain Stem; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Tomography, X-Ray Computed | 1992 |
[Fluconazole treatment of cryptococcal meningitis associated with HIV infection. Presentation of 4 cases].
Topics: Administration, Oral; Adult; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; HIV Infections; Humans; Length of Stay; Male; Meningitis, Cryptococcal; Time Factors | 1992 |
Favourable outcome of blastomycosis of the brain stem with fluconazole and flucytosine treatment.
Topics: Administration, Oral; Adult; Blastomyces; Blastomycosis; Brain Stem; Drug Therapy, Combination; Encephalitis; Fluconazole; Flucytosine; France; Humans; Male; Time Factors; Tunisia | 1992 |
Fluconazole: a position statement by the Society of Infectious Diseases Pharmacists.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Societies, Pharmaceutical | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV-1; Homosexuality; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Substance Abuse, Intravenous | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Recurrence | 1992 |
Candida zeylanoides: another opportunistic yeast.
Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length | 1991 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Opportunistic Infections; Recurrence; Time Factors; Zidovudine | 1991 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosine; HIV Infections; HIV-1; Humans; Male | 1991 |
Hepatosplenic candidiasis: successful treatment with fluconazole.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Candidiasis; Child; Child, Preschool; Fluconazole; Flucytosine; Humans; Leukemia; Liver Diseases; Remission Induction; Splenic Diseases; Tomography, X-Ray Computed | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; Cryptococcosis; Delphi Technique; Drug Therapy, Combination; Fluconazole; Flucytosine; Hospitalization; Humans; Infusions, Intravenous; Meningitis; Models, Theoretical; Surveys and Questionnaires | 1991 |
Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type.
Topics: Amphotericin B; Brain; Brain Abscess; Fluconazole; Flucytosine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitosporic Fungi; Mycoses; United States | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1991 |
Histoplasma capsulatum infection associated with continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Histoplasma; Histoplasmosis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1991 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prototheca | 1991 |
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Chromatography, Gas; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis; Mice; Mice, Inbred BALB C | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Lung Diseases, Fungal; Miconazole; Mycoses | 1990 |
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Animals; Candidiasis; Chronic Disease; Disease Models, Animal; Female; Fluconazole; Flucytosine; Kidney; Liver; Rabbits; Specific Pathogen-Free Organisms | 1990 |
Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male; Meningitis | 1990 |
[Antifungal agents].
Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Injections, Intraventricular; Injections, Spinal; Miconazole; Mycoses | 1990 |
In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
Topics: Amphotericin B; Candida; Drug Evaluation; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests; Species Specificity | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses | 1990 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Microbial Sensitivity Tests | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
Topics: Amphotericin B; Animals; Candidiasis; Colony Count, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Spleen | 1995 |
Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
Topics: Amphotericin B; Brain Abscess; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Tomography, X-Ray Computed | 1995 |
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1995 |
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
Topics: Amphotericin B; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Yeasts | 1995 |
Urinary tract candidiasis in neonates and infants.
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male; Urinary Tract Infections | 1995 |
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mycoses; Yeasts | 1995 |
High prevalence of antifungal resistance in Candida spp. from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 1994 |
Cryptococcosis after renal transplantation.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 1995 |
Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cell Death; Dexamethasone; Female; Fluconazole; Flucytosine; Liposomes; Macrophages; Macrophages, Peritoneal; Mice; Pentoxifylline; Tumor Necrosis Factor-alpha | 1994 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 1995 |
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles | 1995 |
Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole.
Topics: Administration, Oral; Animals; Candida; Candidiasis; Endophthalmitis; Fluconazole; Flucytosine; Rabbits | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests; Molecular Epidemiology | 1995 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Infant, Low Birth Weight; Infant, Newborn; Meningitis, Fungal; Sepsis | 1994 |
Etest for antifungal susceptibility testing of yeasts.
Topics: Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mycology; Yeasts | 1994 |
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Quality Control; Reference Values; Saccharomyces cerevisiae; Yeasts | 1994 |
Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Colorimetry; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Reference Standards; Reference Values; Yeasts | 1994 |
Verticillium peritonitis in a patient on peritoneal dialysis.
Topics: Adult; Fluconazole; Flucytosine; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Mycology; Oxidation-Reduction; Yeasts | 1994 |
Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Flucytosine; Humans; Infant, Newborn; Risk Factors | 1994 |
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Male; Mice; Microbial Sensitivity Tests | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
Topics: Amphotericin B; Blood Physiological Phenomena; Candida albicans; Flow Cytometry; Fluconazole; Flucytosine; Humans | 1994 |
[Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
Topics: Aged; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged | 1993 |
Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency.
Topics: Agammaglobulinemia; Amphotericin B; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Genetic Linkage; Humans; Immunoglobulin M; Male; X Chromosome | 1994 |
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Topics: Amphotericin B; Aspergillus; Candida; Child; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Mycoses | 1993 |
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Topics: Amphotericin B; Bacterial Infections; Bone Marrow Transplantation; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Penicillium; Phenotype | 1993 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Gastrointestinal Diseases; Mice | 1993 |
[Fungal meningitis caused by a Malassezia species masquerading as painful ophthalmoplegia].
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Malassezia; Meningitis, Fungal; Mycoses; Ophthalmoplegia | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Female; Fluconazole; Flucytosine; Humans; Instillation, Drug; Lung; Lung Diseases, Fungal; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Radiography; Time Factors; Treatment Outcome | 1993 |
Successful antifungal treatment of disseminated candidiasis associated with ARDS.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Middle Aged; Opportunistic Infections; Respiratory Distress Syndrome | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodotorula | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus neoformans; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Oxidation-Reduction; Species Specificity; Yeasts | 1995 |
In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Drug Combinations; Fluconazole; Flucytosine; Microbial Sensitivity Tests | 1995 |
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Brain Edema; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Lactates; Lactic Acid; Leukocyte Count; Meningitis, Cryptococcal; Rabbits | 1996 |
[Colorimetric broth microdilution for antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Evaluation Studies as Topic; Fluconazole; Flucytosine; Fungi; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Peptides | 1996 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Immunologic Deficiency Syndromes | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Flucytosine; Genetic Variation; Humans; Itraconazole; Molecular Epidemiology | 1996 |
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Clinical Trials as Topic; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Humans; Logistic Models; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Multivariate Analysis; Treatment Failure | 1996 |
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Miconazole; Microbial Sensitivity Tests | 1996 |
Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Birth Weight; Candidiasis; Congenital Abnormalities; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests | 1996 |
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and flucona
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Glucose; Humans; Indicator Dilution Techniques; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Quality Control | 1996 |
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Body Weight; Brain; Cryptococcus neoformans; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Analysis | 1996 |
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Indicator Dilution Techniques; Microbial Sensitivity Tests | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Itraconazole; Male | 1996 |
[The clinical course of fungal urinary tract infection in neonates].
Topics: Antifungal Agents; Candida albicans; Fluconazole; Flucytosine; Humans; Infant, Newborn; Ultrasonography; Urinary Tract; Urinary Tract Infections | 1996 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Multiple; Female; Fluconazole; Flucytosine; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Mice; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Virulence | 1997 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Leg Dermatoses | 1997 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
[Focusing on therapy of systemic mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Mycoses | 1995 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Body Weight; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Survival Rate | 1997 |
Can we agree on the treatment of candidiasis?
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Neutropenia | 1997 |
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Fungemia; Humans; Incidence; Infant; Injections, Intravenous; Male; Middle Aged; Retrospective Studies | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Treatment of cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Research Design; Selection Bias | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Saccharomyces cerevisiae | 1995 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection.
Topics: Adult; Aged; Amphotericin B; Amputation, Surgical; Antifungal Agents; Arthrodesis; Candidiasis; Diplopia; Fatal Outcome; Female; Fluconazole; Flucytosine; Hemofiltration; Hernia, Inguinal; Humans; Male; Meningococcal Infections; Osteomyelitis; Pulmonary Ventilation; Vitrectomy | 1997 |
Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
Topics: Administration, Oral; Aged; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Liver Transplantation; Male | 1998 |
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Body Weight; Brain; Drug Therapy, Combination; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Specific Pathogen-Free Organisms; Survival Analysis | 1998 |
Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Yeasts | 1998 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Bone Marrow; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Liver; Lung; Lymph Nodes; T-Lymphocytopenia, Idiopathic CD4-Positive | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Laboratories; Microbial Sensitivity Tests; Quality Control; Time Factors | 1998 |
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin | 1998 |
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Evaluation Studies as Topic; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cluster Analysis; Cryptococcus neoformans; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Karyotyping; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Phylogeny; Uganda | 1998 |
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; DNA, Fungal; DNA, Ribosomal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Restriction Mapping; RNA, Ribosomal | 1999 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Topics: Acute Disease; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Cohort Studies; Cryptococcosis; Data Interpretation, Statistical; Female; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Spain; Treatment Outcome | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sex Factors; Spain; Yeasts | 1999 |
The prognostic factors of cryptococcal meningitis in HIV-negative patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prognosis; Taiwan; Treatment Outcome | 1999 |
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Synergism; Fluconazole; Flucytosine; Humans; Lactoferrin; Microbial Sensitivity Tests | 1999 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; Endophthalmitis; Fluconazole; Flucytosine; Kidney; Male; Microbial Sensitivity Tests; Myocardium; Pyelonephritis; Rabbits; Survival Analysis; Time Factors; Vitreous Body | 1999 |
Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunocompetence; Male; Meningitis | 1999 |
In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
Topics: Antifungal Agents; Chromoblastomycosis; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests | 1999 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Leprostatic Agents; Rifampin; Time Factors | 2000 |
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2000 |
Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Seasons; Taiwan | 2000 |
Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Germany; HIV Seropositivity; Humans; Itraconazole; Mycoses; Penicillium; Thailand; Travel | 1999 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Digestive System; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Neutropenia; Oropharynx; Phenotype; Urogenital System | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies | 2000 |
In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Periapical Periodontitis; Periodontitis | 2000 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillus; Candida; Cryptococcus; Drug Resistance, Microbial; Drug Synergism; Fluconazole; Flucytosine; Fungi; Histatins; Humans; Magainins; Microbial Sensitivity Tests; Salivary Proteins and Peptides; Xenopus Proteins | 2000 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
[Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Intensive Care Units; Neutrophils | 2000 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Fungemia; Humans; Male; Postoperative Complications; Risk Factors; Slovakia; Survival Rate | 2001 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Mycology; Mycoses; Neutropenia; Prognosis; Risk Factors; Travel | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucytosine; France; Humans; Intensive Care Units; Mycoses; Surveys and Questionnaires | 2001 |
Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine.
Topics: Abscess; Adult; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Magnetic Resonance Imaging; Osteomyelitis; Thoracic Vertebrae | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
SDT1/SSM1, a multicopy suppressor of S-II null mutant, encodes a novel pyrimidine 5'-nucleotidase.
Topics: 5'-Nucleotidase; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Escherichia coli; Fluconazole; Flucytosine; Fluorouracil; Fungal Proteins; Molecular Sequence Data; Nucleotidases; Phosphorylation; Protein Binding; Recombinant Proteins; Ribosomal Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity | 2002 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brain Abscess; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Male | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Flucytosine; Heart Valve Prosthesis; Humans; Male; Middle Aged; Swine | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candida; Drug Interactions; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Models, Biological | 2002 |
Successful treatment of cryptococcal osteomyelitis and paraspinous abscess.
Topics: Abscess; Antifungal Agents; Cryptococcosis; Fluconazole; Flucytosine; Humans; Osteomyelitis; Thoracic Vertebrae | 2002 |
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Organ Transplantation | 2002 |
In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
Topics: Amphotericin B; Antifungal Agents; Arthroplasty, Replacement; Bone Cements; Candida; Colony Count, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoses; Polymethyl Methacrylate; Postoperative Complications | 2002 |
Cryptococcal meningitis in a patient with systemic immunosuppression 13 years after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Germany; Humans; Immunocompromised Host; Liver Transplantation; Male; Meningitis, Cryptococcal | 2002 |
Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Flucytosine; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate | 2002 |
[A clinical study of 26 cases of cryptococcal meningitis].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Child; Cryptococcus; Drainage; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Lupus Erythematosus, Systemic; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2002 |
Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Spain; Trichosporon | 2003 |
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.
Topics: Antifungal Agents; Biological Transport; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Phenotype | 2003 |
Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus neoformans; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
A very low birth weight infant with Candida nephritis with fungus balls. Full recovery after pyelotomy and antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Kidney; Male; Nephritis; Urologic Surgical Procedures | 2003 |
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EU
Topics: Advisory Committees; Antifungal Agents; Candida; Europe; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Reproducibility of Results | 2003 |
Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Time Factors | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Body Weight; Brain; Colony Count, Microbial; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Combinations; Fluconazole; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Analysis | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx | 2004 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamethasone; Disease Progression; Drug Therapy, Combination; Fluconazole; Flucytosine; Headache; Humans; Hydrocephalus; Immunocompetence; Male; Meningitis, Cryptococcal; Prednisone; Ventriculoperitoneal Shunt | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
Balamuthia mandrillaris from soil samples.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Azithromycin; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Fluconazole; Flucytosine; Fluorescent Antibody Technique, Indirect; Genes, rRNA; Lobosea; Microscopy; Molecular Sequence Data; Parasitic Sensitivity Tests; Pentamidine; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil; Sulfadiazine | 2004 |
In vitro method to study antifungal perfusion in Candida biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biological Assay; Candida; Candida albicans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Micropore Filters; Microscopy, Electron, Scanning | 2005 |
Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Costa Rica; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies; Risk Factors | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans | 2005 |
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Intracranial Hypertension; Lateral Ventricles; Meningitis, Cryptococcal; Middle Aged; Neurosurgical Procedures; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt | 2005 |
In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Topics: Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Microbial Sensitivity Tests; Mucorales; Peptides, Cyclic | 2005 |
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.
Topics: Amino Acid Sequence; Antifungal Agents; Candida; Chromosome Walking; Cloning, Molecular; Cytosine; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Deletion; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleobase Transport Proteins; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Flucytosine; Fungemia; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lipopeptides; Male; Peptides, Cyclic; Retrospective Studies | 2005 |
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Injections, Intraperitoneal; Injections, Intravenous; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prognosis; Retrospective Studies; Risk Factors; Time Factors | 2005 |
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Peptides, Cyclic | 2005 |
Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Therapy, Combination; Fertilization in Vitro; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Peritonitis; Treatment Outcome | 2005 |
Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fluconazole; Flucytosine; Fluoresceins; Fluorometry; Miconazole; Microbial Sensitivity Tests | 2006 |
[Cryptococcal meningitis disclosed by visual loss in HIV negative patient with ventriculo-atrial shunting].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Blindness; Cerebrospinal Fluid Shunts; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; Fludrocortisone; Follow-Up Studies; HIV Seronegativity; Humans; Hydrocephalus; Hydrocortisone; Male; Meningitis, Cryptococcal; Middle Aged; Prednisolone; Sarcoidosis; Time Factors; Treatment Outcome | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic | 2005 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Coccidioidomycosis with cerebral and cerebellar granulomas.
Topics: Adult; Antifungal Agents; Arizona; Central Nervous System Fungal Infections; Cerebellar Diseases; Coccidioides; Coccidioidomycosis; Dermatomycoses; Fluconazole; Flucytosine; Granuloma; Humans; Male; Travel | 2006 |
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Prognosis; Treatment Outcome | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2006 |
[Mycotic complications of shunt infection in children with primary hydrocephalus].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cerebrospinal Fluid; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Hydrocephalus; Infant; Injections, Intravenous; Injections, Intraventricular; Male; Ventriculoperitoneal Shunt | 2002 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fingerprinting; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Hospital Units; Humans; Microbial Sensitivity Tests; Turkey | 2006 |
Combined antifungal therapy in a murine infection by Candida glabrata.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic; Spleen; Survival Analysis | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Molluscum or a mimic?
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Diagnosis, Differential; Fluconazole; Flucytosine; HIV Seropositivity; Humans; Male; Molluscum Contagiosum | 2006 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
Topics: Amino Acid Sequence; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Combinatorial Chemistry Techniques; Cryptococcus neoformans; Drug Synergism; Erythrocytes; Fluconazole; Flucytosine; Fungi; Hemolysis; Inhibitory Concentration 50; Microbial Sensitivity Tests; Oligopeptides; Rabbits | 2007 |
Endophthalmitis due to Trichosporon beigelii in acute leukemia.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Female; Fluconazole; Flucytosine; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporon | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; False Positive Reactions; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reagent Strips; Reproducibility of Results | 2008 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebrospinal Fluid; Cryptococcus neoformans; Dacarbazine; Dexamethasone; Fatal Outcome; Fluconazole; Flucytosine; Glioma; Humans; Immunosuppression Therapy; Lomustine; Male; Meningitis, Cryptococcal; Opportunistic Infections; Temozolomide; Treatment Outcome | 2008 |
In vitro susceptibility of Cryptococcus gattii clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles | 2008 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2009 |
Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast.
Topics: Amino Acid Sequence; Antifungal Agents; Cytochrome P-450 Enzyme System; Cytosine Deaminase; DNA, Fungal; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Flucytosine; Genes, Fungal; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nucleobase Transport Proteins; Orotate Phosphoribosyltransferase; Oxidoreductases; Pentosyltransferases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transformation, Genetic | 2008 |
Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Flucytosine; Humans; Immunocompetence; Intracranial Hypertension; Itraconazole; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Spinal Puncture; Ventriculoperitoneal Shunt | 2008 |
Pulmonary cryptococcosis in non-AIDS patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; DNA, Fungal; DNA, Ribosomal Spacer; Drainage; Female; Fluconazole; Flucytosine; Humans; Meningoencephalitis; Middle Aged; Molecular Sequence Data; Phylogeny; Sequence Analysis, DNA; Switzerland; Travel | 2009 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Removal; Fluconazole; Flucytosine; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis | 2009 |
Intraocular cryptococcoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Ultrasonography; Vitrectomy; Vitreous Body | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
Topics: Antifungal Agents; Biofilms; Cell Proliferation; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Microbial Sensitivity Tests; Temperature; Tetrazolium Salts | 2010 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Genotyping of the MTL loci and susceptibility to two antifungal agents of Candida glabrata clinical isolates.
Topics: Antifungal Agents; Candida glabrata; Fluconazole; Flucytosine; Genes, Mating Type, Fungal; Genotype; Humans; Mexico; Microbial Sensitivity Tests | 2009 |
Successful treatment of Candida discitis with 5-flucytosine and fluconazole.
Topics: Antifungal Agents; Candidemia; Discitis; Female; Fluconazole; Flucytosine; Humans; Middle Aged | 2010 |
The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus neoformans; Drug Delivery Systems; Female; Fluconazole; Flucytosine; Humans; Intracranial Hypertension; Male; Meningitis, Cryptococcal | 2010 |
Candida parapsilosis meningitis associated with shunt infection in an adult male.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida; Candidiasis; Drainage; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Injections, Intravenous; Male; Meningitis, Bacterial; Middle Aged; Recurrence; Treatment Outcome; Ventriculoperitoneal Shunt | 2010 |
Drug susceptibility of 64 strains of Rhodotorula sp.
Topics: Amphotericin B; Antifungal Agents; Feces; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Rhodotorula; Skin; Species Specificity; Vagina | 2010 |
Cutaneous septic emboli from Candida tropicalis.
Topics: Antifungal Agents; Biopsy; Candida tropicalis; Candidiasis; Child; Embolism; Female; Fluconazole; Flucytosine; Humans; Skin Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Female; Fluconazole; Flucytosine; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Neutropenia; Prednisolone; Rituximab; Treatment Outcome; Vincristine | 2011 |
Candida urinary tract infections--treatment.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Candidiasis, Invasive; Causality; Echinocandins; Fluconazole; Flucytosine; Humans; Urinary Tract Infections | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Osteoarticular infection by Candida albicans in an infant with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidemia; Candidiasis, Invasive; Cystic Fibrosis; Female; Fluconazole; Flucytosine; Humans; Infant; Osteoarthritis; Treatment Outcome | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Cryptococcal meningitis in immunocompetent children.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Child, Preschool; Cryptococcus neoformans; Drug Administration Schedule; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Male; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2012 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
Cryptococcus neoformans: the model organism for yeast antifungal drug susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Culture Media; Drug Combinations; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests | 2012 |
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.
Topics: Aged; Aged, 80 and over; Candida; Candidiasis; Child; DNA, Ribosomal; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Genotype; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Genetic; Mycological Typing Techniques; Prevalence; Prospective Studies; Time Factors | 2012 |
Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes.
Topics: Asia; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Genetic Variation; Genotype; HIV Infections; Humans; Microsatellite Repeats; Polymerase Chain Reaction; Serotyping | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Middle Aged; Recurrence; Retinal Diseases; Tomography, X-Ray Computed; Vitreous Body | 2012 |
Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
Topics: Africa South of the Sahara; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Developing Countries; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; Practice Guidelines as Topic | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Imidazoles | 2012 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
Topics: Africa; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2012 |
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Case-Control Studies; Colony Count, Microbial; Cross-Sectional Studies; DMF Index; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Humans; Hydroxyurea; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Saliva; Secretory Rate; Young Adult | 2013 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Administration Schedule; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Incidence; Male; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
Treating cryptococcal meningitis in people with HIV.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal | 2013 |
Comparison of MICs of fluconazole and flucytosine when dissolved in dimethyl sulfoxide or water.
Topics: Antifungal Agents; Candida; Dimethyl Sulfoxide; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Solvents; Water | 2013 |
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Time Factors; Treatment Outcome | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole | 2013 |
Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine.
Topics: Amphotericin B; Antifungal Agents; Calorimetry; Candida albicans; Fluconazole; Flucytosine; Glucose; Humans; Imidazoles; Microbial Sensitivity Tests; Urinary Tract Infections; Urine | 2013 |
Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Chromosomes, Fungal; Echinocandins; Fluconazole; Flucytosine; Lipopeptides | 2013 |
Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida glabrata; Drug Antagonism; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression Regulation, Fungal; Mitochondria; Transcription Factors | 2013 |
Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Disease Models, Animal; Fluconazole; Flucytosine; Larva; Moths | 2013 |
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Child; Cryptococcus; Female; Fluconazole; Flucytosine; Hepatitis B; Hepatitis B virus; Humans; Liver Cirrhosis; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus).
Topics: Animals; Antifungal Agents; Bird Diseases; Cryptococcosis; Cryptococcus gattii; Drug Compounding; Female; Fluconazole; Flucytosine; Itraconazole; Osteomyelitis; Psittaciformes; Treatment Failure | 2014 |
Cryptococcal meningitis post autologous stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Male; Meningitis, Cryptococcal; Stem Cell Transplantation; Transplantation, Autologous | 2014 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2014 |
Cryptococcal meningitis caused by Cryptococcus neoformans in an immunocompetent soldier.
Topics: Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Military Personnel; Spinal Puncture; Young Adult | 2014 |
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole | 2014 |
Pulmonary cryptococcosis with endobronchial lesions and meningitis.
Topics: Amphotericin B; Animals; Bronchi; Bronchoscopy; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Lung; Male; Meningitis, Cryptococcal; Middle Aged; Treatment Outcome | 2014 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
Hidden in a headache: cryptococcal meningitis in a septuagenarian.
Topics: Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Headache; Humans; Meningitis, Cryptococcal | 2015 |
Caspofungin irrigation through percutaneous calicostomy catheter combined with oral flucytosine to treat fluconazole-resistant symptomatic candiduria.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Combined Modality Therapy; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Kidney Calices; Lipopeptides; Male; Therapeutic Irrigation; Urinary Catheterization; Urinary Tract Infections | 2015 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Flucytosine; Hospitals, Urban; Humans; Male; Medical Audit; Meningitis, Cryptococcal; Retrospective Studies; South Africa; Treatment Outcome | 2014 |
Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Immunodiffusion; Microbial Sensitivity Tests; Prospective Studies; Tablets; Voriconazole | 2016 |
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Species Specificity; United Kingdom; Urinary Tract Infections | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; United States | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Flucytosine; Fungemia; Glomerulosclerosis, Focal Segmental; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prednisone; Skin | 2016 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Chromatography, Liquid; Drug Monitoring; Fluconazole; Flucytosine; Humans; Online Systems; Solid Phase Extraction; Tandem Mass Spectrometry | 2017 |
Necrotic ulcer on the thigh.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Diagnosis, Differential; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Ulcer; Thigh | 2017 |
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole | 2018 |
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Topics: Adult; Amphotericin B; Antifungal Agents; Chloramphenicol; Cote d'Ivoire; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; DNA, Fungal; Environmental Microbiology; Female; Fluconazole; Flucytosine; Genotype; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Prospective Studies; Serotyping; Young Adult | 2018 |
A Rare Presentation of Cryptococcal Meningitis and Cerebellitis in an Asplenic Patient, Seronegative for Human Immunodeficiency Virus (HIV).
Topics: Aged; Amphotericin B; Antifungal Agents; Cerebellar Diseases; Cryptococcus neoformans; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Flucytosine; Follow-Up Studies; HIV Seronegativity; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Rare Diseases; Risk Assessment; Severity of Illness Index; Splenectomy; Treatment Outcome | 2018 |
Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptococcus gattii; Drug Therapy, Combination; Eye Diseases; Eye Infections, Fungal; Fluconazole; Flucytosine; HIV Infections; Humans; Infusions, Intravenous; Male; Meningitis, Cryptococcal; Retinitis; Tomography, Optical Coherence; Vitreous Body | 2018 |
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult | 2018 |
Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Brain Ischemia; Cryptococcus neoformans; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Malawi; Male; Meningitis, Cryptococcal; Stroke | 2018 |
Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; Candida albicans; Caspases; Catalase; Cell Membrane; Cell Membrane Permeability; Drug Combinations; Drug Synergism; Enzyme Activation; Fluconazole; Flucytosine; Free Radical Scavengers; Microbial Sensitivity Tests; Oxidative Stress; Quercetin; Reactive Oxygen Species; Superoxide Dismutase | 2019 |
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Child; Cryptococcus; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; HIV Infections; Humans; Maintenance Chemotherapy; Meningitis, Cryptococcal; Practice Guidelines as Topic; World Health Organization | 2018 |
High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Patient Compliance; Retrospective Studies; Salvage Therapy; Young Adult | 2018 |
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus; Drug Synergism; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2019 |
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.
Topics: Africa; Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2020 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcus neoformans; Extracorporeal Membrane Oxygenation; Fluconazole; Flucytosine; Heart-Assist Devices; Humans; Immunocompetence; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Septic; ST Elevation Myocardial Infarction | 2019 |
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Organ Transplantation; Retrospective Studies; Treatment Outcome | 2019 |
Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Fungal Proteins; Genotype; Germany; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Mutation; Mycological Typing Techniques | 2019 |
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Topics: Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Follow-Up Studies; Genetic Variation; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mycological Typing Techniques | 2019 |
An AIDS patient with urine retention.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; China; Cryptococcosis; Cryptococcus neoformans; Delayed Diagnosis; Diagnostic Errors; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Prostatitis; Treatment Outcome; Urinary Retention; Voriconazole | 2019 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Disseminated cutaneous cryptococcosis in an immunocompetent elderly long-term pigeon fancier.
Topics: Administration, Cutaneous; Aged; Animals; Antifungal Agents; Columbidae; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Skin; Treatment Outcome | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents; Antifungal Agents; Arachnoid; Arachnoiditis; Biopsy; Brain; Brain Abscess; Brain Edema; Cerebellar Diseases; Empyema, Subdural; Fluconazole; Flucytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Prednisone; Recurrence | 2020 |
Cryptococcal meningitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Culture Techniques; Delayed Diagnosis; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompetence; Intensive Care Units; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Papilledema; Respiratory Insufficiency; Spinal Puncture; Ventriculoperitoneal Shunt | 2020 |
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Missouri; Treatment Outcome | 2021 |
Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Hypertension; Length of Stay; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Spinal Puncture; Treatment Outcome; Ventriculoperitoneal Shunt | 2020 |
HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Topics: Adult; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Referral and Consultation; Retrospective Studies | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Cryptococcal infection presenting as soft tissue abscess and arthritis: Case report.
Topics: Abscess; Aged; Antifungal Agents; Arthritis; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged | 2021 |
Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Topics: Adaptation, Physiological; Amphotericin B; Aneuploidy; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Serogroup | 2021 |
The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida parapsilosis; Diet, High-Fat; Fluconazole; Flucytosine; Male; Mice; Mice, Inbred C57BL; Obesity; Symbiosis | 2021 |
Multilocus sequence typing of strains from the Cryptococcus gattii species complex from different continents.
Topics: Cryptococcosis; Cryptococcus gattii; Fluconazole; Flucytosine; Genotype; Humans; Multilocus Sequence Typing; Mycological Typing Techniques | 2022 |
Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary
Topics: Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Immune Reconstitution Inflammatory Syndrome | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study.
Topics: Adult; Antifungal Agents; Cross-Sectional Studies; Cryptococcosis; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; South Africa | 2022 |
Access to flucytosine for the treatment of HIV-associated cryptococcal meningitis in Africa.
Topics: Africa; AIDS-Related Opportunistic Infections; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Single-Dose Amphotericin B for Cryptococcal Meningitis. Reply.
Topics: Amphotericin B; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal | 2022 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
Antifungal susceptibility of the clinical and environmental strains of Cryptococcus gattii sensu lato in Taiwan.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Taiwan | 2023 |
Induction therapy with high-dose fluconazole plus flucytosine for human immunodeficiency virus-uninfected cryptococcal meningitis patients: Feasible or not?
Topics: Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Retrospective Studies | 2023 |
Cryptococcus neoformans Presenting as a Lung Mass in an Immunocompromised Patient.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Flucytosine; Headache; Humans; Immunocompromised Host; Lung; Middle Aged | 2022 |
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
Topics: Antifungal Agents; Botswana; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Meningitis, Cryptococcal; Uganda | 2022 |
Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies; Saccharomyces cerevisiae | 2023 |
Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Democratic Republic of the Congo; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fluorouracil; HIV Infections; Humans; Microbial Sensitivity Tests; Polymorphism, Genetic | 2023 |
Cross-feeding affects the target of resistance evolution to an antifungal drug.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungi; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 2023 |